Development of live biotherapeutic products: a position statement of Asia-Pacific Microbiota Consortium
The development of LBP should be approached with a strong emphasis on microbiological evaluation, clinical relevance, scientific mechanisms and safety at every stage. These measures are essential to ensure the safety, effectiveness and long-term success of the product.
Authors
- Sung‐Liang Yu (ORCID: https://orcid.org/0000-0003-4535-9036)
- Emad El‐Omar (ORCID: https://orcid.org/0000-0002-0011-3924)
- Chun‐Ying Wu (ORCID: https://orcid.org/0000-0001-5053-1801)
- Ming‐Chih Hou (ORCID: https://orcid.org/0000-0002-4886-0718)
- Sunny H. Wong (ORCID: https://orcid.org/0000-0002-3354-9310)
- Cheng‐Yen Kao (ORCID: https://orcid.org/0000-0001-8782-3912)
- Yeong Yeh Lee (ORCID: https://orcid.org/0000-0002-6486-7717)
- Jiing‐Chyuan Luo (ORCID: https://orcid.org/0000-0003-4306-5464)
- Joseph J.�Y. Sung (ORCID: https://orcid.org/0000-0003-3125-5199)
- Jyh‐Ming Liou (ORCID: https://orcid.org/0000-0002-7945-5408)
- Deng‐Chyang Wu (ORCID: https://orcid.org/0000-0003-3742-0634)
- Jun Terauchi
- Hsin‐Chih Lai (ORCID: https://orcid.org/0000-0002-0605-5040)
- Jun Qing Yu (ORCID: https://orcid.org/0000-0001-5008-2153)
- Ching‐Hung Tseng (ORCID: https://orcid.org/0000-0002-6026-9015)
- Jiunn‐Jong Wu
- Ming-Shiang Wu
Institutions
- Asia University (TW)
- National Yang Ming Chiao Tung University (TW)
- Kaohsiung Medical University (TW)
- National Taiwan University (TW)
- Nanyang Technological University (SG)
- Chang Gung University (TW)
- Chinese University of Hong Kong (HK)
- China Medical University (TW)
- Kaohsiung Medical University Chung-Ho Memorial Hospital (TW)
- Taipei Veterans General Hospital (TW)
- UNSW Sydney (AU)
- Hospital Universiti Sains Malaysia (MY)
- TaiGen Biotechnology (Taiwan) (TW)
- Japan Biological Informatics Consortium (JP)
- National Taiwan University Hospital (TW)
- National Yang Ming Chiao Tung University (TW)
Publication Details
- Journal
- Gut
- Published
- 2025-02-26
- DOI
- https://doi.org/10.1136/gutjnl-2024-334501
- Citations
- 19
- Primary Topic
- Clostridium difficile and Clostridium perfringens research
- Type
- article
- Field-Weighted Citation Impact
- 26.53